Status: Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Multicenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.
Participants needed: 180
Trial details
Phase: Phase 2Age: 55-84Biological sex: AllType: InterventionalSponsor: ACADIA Pharmaceuticals Inc.Updated: Jun 30, 2026Locations: 57
Eligibility criteria
Male or female ≥55 years to <85 years of age at the Screening visit living in th... [+4]
Is in hospice, is receiving end-of-life palliative care, or is bedridden [+4]